Table 4.
First author, year | Intervention | Mean costs (95% CI)/[SD] | Mean outcomes (95% CI)/[SD] | Incremental cost (95% CI)/[SD] | Incremental effect (95% CI)/[SD] | Incremental cost-effectiveness | CEAC | CEP |
---|---|---|---|---|---|---|---|---|
Crawley, 2018 [19] | LP and SpMC (n = 51) | £2002 [£67]a | 0.628 QALYs [0.021] | £390 (£189–£591) | 0.095 QALYs (0.030–0.160) | £1508 (£148–£2869) iNMB | Y | N |
SpMC (n = 49) | £1612 [£84]a | 0.533 QALYs [0.025] | NA | NA | NA |
CI confidence interval, iNMB incremental net monetary benefit, N no, NA not applicable, LP lightning process, QALYs quality-adjusted life-year, SD standard deviation, SpMC specialist medical care, Y yes, CEAC cost-effectiveness acceptability curve, CEP cost-effectiveness plane
aHealth care and public sector perspective